Provided by Tiger Fintech (Singapore) Pte. Ltd.

Eli Lilly

780.67
+1.390.18%
Post-market: 778.00-2.6700-0.34%16:58 EDT
Volume:1.45M
Turnover:1.13B
Market Cap:739.87B
PE:66.67
High:783.55
Open:780.46
Low:773.00
Close:779.28
Loading ...

Eli Lilly and Loxo Oncology’s Promising CLL/SLL Study Update

TIPRANKS
·
Yesterday

This GLP-1 Stock's Bad News Could Be a Big Win for Eli Lilly and Novo Nordisk

Motley Fool
·
02 Jul

Tests Show Eli Lilly’s (LLY) Weight-Loss Pill Works as Well as Injection

TIPRANKS
·
02 Jul

Eli Lilly Stock (LLY) Consolidates in Value Territory

TIPRANKS
·
01 Jul

Eli Lilly & Co. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
28 Jun

UBS Sticks to Their Buy Rating for Eli Lilly & Co (LLY)

TIPRANKS
·
28 Jun

Eli Lilly’s Orforglipron Study: A Potential Game-Changer for Sleep Apnea Treatment

TIPRANKS
·
28 Jun

Eli Lilly’s Phase 1 Study on LY3410738: A Potential Breakthrough for Advanced Solid Tumors

TIPRANKS
·
28 Jun

Eli Lilly 'Clear Leader in Obesity' Drugs, UBS Says; Raises 2025 Earnings Forecast

MT Newswires Live
·
27 Jun

Update: Eli Lilly's Mounjaro KwikPen Approved by India

MT Newswires Live
·
27 Jun

Eli Lilly and AstraZeneca’s Promising Phase 3 Study on KRAS G12C-Mutant NSCLC

TIPRANKS
·
27 Jun

Eli Lilly’s Mirikizumab Study: A Potential Game-Changer for Ulcerative Colitis

TIPRANKS
·
27 Jun

Lilly to launch Mounjaro pen in India as Novo rivalry heats up in mega market

Reuters
·
26 Jun

BRIEF-MHRA's Yellow Card Biobank To Probe Genetic Influence On Acute Pancreatitis Risk From GLP-1 Injections

Reuters
·
26 Jun

UK's Mhra: Yellow Card Biobank to Probe IF Risk of Acute Pancreatitis From Glp-1 Injections May Be Influenced by an Individual’s Genes - Website

THOMSON REUTERS
·
26 Jun

UK's Mhra: Patients Hospitalised With Acute Pancreatitis Suspected to Be Related to Glp-1 Medicines Being Asked to Report It to Yellow Card Scheme

THOMSON REUTERS
·
26 Jun

BRIEF-Eli Lilly Gets India Drug Regulator Nod For Pen Form Of Mounjaro 'Kwikpen' - Statement

Reuters
·
26 Jun

Lilly's Mounjaro Pen to Be Available in All Doses From 2.5 Mg to 15 Mg in India - Statement

THOMSON REUTERS
·
26 Jun

Eli Lilly Gets India Drug Regulator Nod for Pen Form of Mounjaro 'Kwikpen' - Statement

THOMSON REUTERS
·
26 Jun

Eli Lilly (LLY) Raises Dividend for 11th Consecutive Year

TIPRANKS
·
26 Jun